RE: The placing was to prevent a5 Jun 2020 08:44
Clearly, the II that just pumped in £45m will be in full knowledge of the Cytiva/Adeptrix results. It will be of no coincidence that the placing occurred just days prior to the test results RNS. With a positive RNS, it would be extremely difficult to prevent a cheap T/O - the potential revenue for AVCT is so large it is, as SIr Al put it, unquantifiable!